Magnesium
Essential mineral cofactor for 300+ enzymatic reactions, widely deficient in modern populations.
Evidence Summary
Magnesium is an essential mineral cofactor for 300+ reactions and is widely under-consumed; deficiency is common and best assessed with RBC magnesium rather than serum. Recent high-quality evidence continues to support cardiovascular, sleep, and cognitive benefits. A 2025 systematic review and meta-analysis in Hypertension (38 RCTs, 2,709 participants; median 365 mg/day for ~12 weeks) found magnesium lowered systolic blood pressure by 2.81 mmHg and diastolic by 2.05 mmHg versus placebo, with much larger reductions in people already on antihypertensive medication (systolic 7.68 mmHg) and in those with low magnesium status (systolic 5.97, diastolic 4.75 mmHg); normotensive groups saw no significant change and no clear dose-response emerged (https://pubmed.ncbi.nlm.nih.gov/41000008/). A 2024 randomized controlled trial in Sleep Medicine: X (80 adults, 1 g/day magnesium-L-threonate for 21 days) reported increased objectively measured deep and REM sleep plus better next-day alertness and mood versus placebo (https://pubmed.ncbi.nlm.nih.gov/39252819/). A 2024 systematic review and meta-analysis in Advances in Nutrition described a U-shaped relationship between serum magnesium and cognitive impairment/dementia, with risk lowest near a serum level of 0.085 mmol/L—underscoring that both deficiency and excess matter (https://advances.nutrition.org/article/S2161-8313(24)00106-6/fulltext). Magnesium is inexpensive and generally well tolerated. Educational information only; not a diagnosis, cure, or treatment claim.
Evidence Scale
Mechanism of Action
Magnesium is a cofactor for ATP production, DNA and protein synthesis, and neuromuscular signaling across 300+ enzymatic reactions. In the vasculature it behaves as a natural calcium antagonist and supports endothelial nitric-oxide–mediated vasodilation, which underlies its modest blood-pressure-lowering effect. Centrally, magnesium-L-threonate can raise brain magnesium and modulate NMDA-receptor and GABAergic tone relevant to sleep architecture and cognition. Different salts target different tissues, so form selection matters.
Who Is This For?
Nearly universal benefit. Sleep issues, muscle cramps, cardiovascular health, metabolic syndrome, stress.
Protocol & Dosing
Dose
300-600mg elemental magnesium daily in divided doses.
Frequency
Daily, often evening
Duration
Ongoing
Protocol Summary
Typical intake is 300–600 mg elemental magnesium daily, often in the evening and in divided doses. Form matters: glycinate/bisglycinate for sleep and relaxation, L-threonate for cognition and sleep architecture, citrate for constipation, malate for energy. For blood pressure, benefit is largest when magnesium status is low or when magnesium is added to existing antihypertensive therapy—it is an adjunct, not a replacement for prescribed medication. Confirm status with RBC magnesium and titrate to tolerance.
Latest Evidence
2024–2025: blood pressure, sleep architecture & cognition
A 2025 systematic review and meta-analysis in Hypertension pooled 38 randomized controlled trials (2,709 participants; median 365 mg/day for about 12 weeks) and found magnesium lowered systolic blood pressure by 2.81 mmHg and diastolic by 2.05 mmHg versus placebo. The effect was concentrated where it matters most: a 7.68 mmHg systolic drop in people already taking antihypertensive medication, and 5.97/4.75 mmHg systolic/diastolic reductions in those with low magnesium status, while normotensive groups saw no significant change and no clear dose-response emerged. A 2024 randomized controlled trial (80 adults, 1 g/day magnesium-L-threonate for 21 days) reported more objectively measured deep and REM sleep plus better next-day alertness and mood. A 2024 systematic review in Advances in Nutrition described a U-shaped link between serum magnesium and cognitive impairment, with risk lowest near a serum level of 0.085 mmol/L.
These are pooled, mostly short-term results with meaningful heterogeneity; magnesium is an adjunct, not a substitute for prescribed antihypertensive therapy, and benefit is greatest when a deficiency is corrected. RBC magnesium reflects status better than serum. Introduce gradually to limit loose stools, reduce the dose and monitor in reduced kidney function, and avoid in severe renal impairment or heart block. Educational information, not medical advice.
Meta-analysis · 38 RCTs · 2025
Magnesium vs placebo: blood-pressure reduction by population
Mean change in blood pressure vs placebo (negative = reduction). Source: systematic review & meta-analysis of 38 randomized controlled trials (n=2,709), Hypertension (AHA), 2025.
Related on Peak Human
Magnesium Glycinate
The paired supplement monograph: forms, dosing and absorption.
Sleep
Magnesium (glycinate/L-threonate) supports sleep quality and architecture.
Hypertension
Magnesium is studied as an adjunct for blood-pressure control.
Diagnostic Testing
Check RBC magnesium to guide dosing and confirm status.
Peak Human Shop
Practitioner-grade magnesium and cofactors.
Longevity Research Insider
Weekly review of new longevity research.
Key references: Magnesium supplementation & blood pressure: meta-analysis of 38 RCTs — Hypertension (2025) · Magnesium-L-threonate improves sleep quality & daytime functioning: RCT — Sleep Medicine: X (2024) · Magnesium & cognitive health in adults: systematic review & meta-analysis — Advances in Nutrition (2024)
Interactions & Precautions
Contraindications
- Severe renal impairment
- Heart block
Potential Risks
- •GI upset with some forms
- •Drowsiness
Potential Side Effects
Practitioner Notes
Clinical annotations from Dr. Goel
Form matters: glycinate for sleep/anxiety, L-threonate for cognition, malate for energy/pain, citrate for constipation. RBC magnesium is a better status marker than serum. Recent data (2024–2025) reinforce that blood-pressure benefit is concentrated in medicated hypertensives and low-magnesium individuals, and that L-threonate improves objective sleep architecture. Introduce gradually to limit loose stools; reduce dose and monitor in reduced kidney function; avoid in severe renal impairment or heart block.
Dr. Sanjeev Goel
Chief Medical Officer, Peak Human
Cost & Access
Cost Range
$
Accessibility
Availability varies by location
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation